These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 35666610

  • 21. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F, Lu Z, Chen B, Dong P, Zheng J.
    Diagn Pathol; 2015 Jul 28; 10():129. PubMed ID: 26215970
    [Abstract] [Full Text] [Related]

  • 22. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM.
    Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):555-562. PubMed ID: 32102538
    [Abstract] [Full Text] [Related]

  • 23. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J, Wu Y, Luo Y, Li X, Lin N, Yang X, Lin Y, Chen M.
    Ann Clin Lab Sci; 2020 Mar 01; 50(2):219-227. PubMed ID: 32366560
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
    Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, Zhou X, Gan J.
    PLoS One; 2014 Mar 01; 9(9):e107986. PubMed ID: 25238238
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
    Eldosoky MA, Hammad R, Elmadbouly AA, Aglan RB, Abdel-Hamid SG, Alboraie M, Hassan DA, Shaheen MA, Rushdi A, Ahmed RM, Abdelbadea A, Abdelmageed NA, Elshafei A, Ali E, Abo-Elkheir OI, Zaky S, Hamdy NM, Lambert C.
    Int J Mol Sci; 2023 Feb 05; 24(4):. PubMed ID: 36834570
    [Abstract] [Full Text] [Related]

  • 29. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z, Gao P, Sun W, Rehman AU, Jiang J, Xu S, Xue C, Zhu C, Qin X.
    Front Endocrinol (Lausanne); 2023 Feb 05; 14():938102. PubMed ID: 36793272
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH.
    World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr 14; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 35. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma.
    Elghoroury EA, Abdelghaffar EE, Awadallah E, Kamel SA, Kandil D, Hassan EM, Hassan M, Kamel MM, Gomaa MM, Fathalla LA.
    Int J Immunopathol Pharmacol; 2022 Apr 14; 36():3946320221097832. PubMed ID: 35467432
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L, Guo L, Hu Y, Huang H, Zhang M, Xu K, De G, Zheng F, Wu Z, Hu C, Wen Z.
    Clin Biochem; 2021 Mar 14; 89():44-50. PubMed ID: 33309517
    [Abstract] [Full Text] [Related]

  • 38. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
    Liu WH, Ren LN, Wang X, Wang T, Zhang N, Gao Y, Luo H, Navarro-Alvarez N, Tang LJ.
    J Cancer Res Clin Oncol; 2015 Oct 14; 141(10):1767-78. PubMed ID: 25724413
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N.
    Cancer Biomark; 2019 Oct 14; 26(4):501-512. PubMed ID: 31658041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.